AMRZ

Amrize AG

$64.16 USD 35.2B market cap February 26, 2026

Amrize AG AMRZ BUFFETT / MUNGER / KLARMAN SUMMARY

1 SNAPSHOT

Price$64.16

Market CapUSD 35.2B

EVUSD 38.5B

Net DebtUSD 3.3B

Shares553.1M

2 BUSINESS

Amrize is North America's largest cement producer and second-largest commercial roofing company, spun off from Holcim in June 2025 with 1,000+ sites across every US state and Canadian province. It operates two segments: Building Materials (cement, aggregates, ready-mix, asphalt - 72% of revenue) and Building Envelope (commercial/residential roofing, insulation, adhesives - 28%). All products are manufactured domestically, providing zero tariff exposure.

Revenue: USD 11.8B Organic Growth: 0.9%

3 MOAT NARROW

Local oligopoly in cement (high weight-to-value ratio limits transport to ~200 miles, creating natural geographic moats). Largest US cement producer with 1.7x the volume of the next competitor. 1,000+ site distribution network impossible to replicate. Regulatory barriers from years-long permitting for new cement plants and aggregate quarries. Vertical integration from cement through ready-mix to roofing. Building Envelope segment faces more competition, pulling overall moat rating toward Narrow rather than Wide.

4 MANAGEMENT

CEO: Jan Jenisch (since June 2025, previously Holcim CEO 2017-2025)

Excellent track record: 130 M&A deals in 6 years while improving margins and reducing leverage from 2.3x to 1.1x net debt/EBITDA. Jenisch personally invested $34M+ in open-market share purchases. Insiders own 7.1% ($2.5B). New $1B buyback authorization plus $0.88/share annual dividend (1.4% yield). Anti-bureaucracy culture with 150 HQ staff out of 19,000 total employees.

5 ECONOMICS

16.5% Op Margin

~13% ROIC

USD 1.42B FCF

1.1x Debt/EBITDA

6 VALUATION

FCF/ShareUSD 2.56

FCF Yield4.0%

DCF RangeUSD 40 - 75

Base case: 8% FCF growth years 1-3 (aligned with guided EBITDA growth of 8-11%), 4% years 4-10, 2.5% terminal growth, 9% discount rate. Bull case uses 10% growth and 15x terminal multiple. Bear case uses 3% growth and 10x terminal multiple reflecting recession scenario.

7 MUNGER INVERSION -28.1%

Kill Event	Severity	P()	E[Loss]
Construction downturn / US recession reduces volumes 20%+	-35%	25%	-8.8%
Valuation multiple compression from 30x to 20x P/E	-20%	30%	-6.0%
Carbon regulation sharply increases cement production costs	-20%	20%	-4.0%
Cement overcapacity from imports or new entrant plants	-25%	15%	-3.8%
M&A integration failures or goodwill impairment on $9B	-20%	15%	-3.0%
Key-man risk: Jan Jenisch departure	-25%	10%	-2.5%

Tail Risk: A severe US recession combined with carbon regulation and multiple compression could see the stock decline 50%+ to the $25-30 range. The $9B goodwill balance creates write-down risk in a downturn. As a recent spin-off, the investor base is still forming - forced selling from index-tracking Holcim holders could create temporary but sharp price dislocations.

8 KLARMAN LENS

Downside Case

In a recession, cement volumes could fall 15-20% while pricing power is tested. EBITDA could compress to $2.0-2.2B, and a multiple re-rating from 13.5x to 8x EV/EBITDA would imply an EV of $16-18B, or roughly $25-27 per share. That is a 60% drawdown from current levels. The cyclicality of construction makes this a real scenario, not a theoretical one.

Why Market Wrong

The market may be underappreciating the structural advantages of being the largest US cement producer in an era of unprecedented infrastructure spending (IIJA, CHIPS Act). The "Made in America" positioning provides tariff immunity. The spin-off is still new - many institutional investors have not yet established positions, and as the company builds a track record as independent, re-rating toward premium US aggregates multiples (17-20x EV/EBITDA) is possible.

Why Market Right

The bears argue correctly that (1) revenue growth has stalled at 0.9%, (2) EBITDA margins are compressing, (3) 30x P/E for a cyclical industrial is aggressive, (4) the spin-off premium will fade as the novelty wears off, and (5) rising CapEx ($788M, up 23%) is consuming more FCF. The stock has rallied 46% from its low in 8 months with deteriorating fundamentals underneath.

Catalysts

(1) Major infrastructure contract wins demonstrating IIJA spend acceleration. (2) Accretive M&A in fragmented aggregates markets. (3) Margin recovery toward 27% EBITDA margins in 2026. (4) Share buyback execution under $1B authorization. (5) Entry into S&P 500 index, driving passive fund buying.

9 VERDICT WAIT

B+ T2 Resilient

Strong Buy$40

Buy$48

Sell$80

Amrize is a high-quality business with genuine competitive moats in North American cement, led by an exceptional CEO with massive personal skin in the game. However, at 30x trailing earnings and 13.5x EV/EBITDA for a cyclical industrial showing declining margins and stalled revenue growth, the stock offers no margin of safety. Wait for a recession pullback or earnings disappointment to create an entry below $48 where the risk-reward becomes compelling.

🧠 ULTRATHINK Deep Philosophical Analysis

AMRZ - Ultrathink Analysis

The Real Question

The real question is not whether Amrize is a good business. It clearly is. The question is more fundamental: Can you get rich paying 30x earnings for a company that makes cement?

Cement is perhaps the most perfectly "Buffett" product imaginable. It's heavy, cheap per unit, essential, and impossible to transport economically over long distances. Every major construction project needs it. Nobody ever disrupted cement. No app replaced it. It's the same product the Romans used to build the Pantheon.

So the investment question boils down to price. And the uncomfortable truth is that the market already knows everything I just said. Jan Jenisch is brilliant, the assets are irreplaceable, the infrastructure cycle is real. It's all priced in. The question becomes: what are you paying for that knowledge, and what could make you wrong?

Hidden Assumptions

The market is making several assumptions that deserve scrutiny:

Assumption 1: Infrastructure spending is secular, not cyclical. The IIJA and CHIPS Act provide multi-year funding, but political winds shift. The current bipartisan consensus on infrastructure could fracture. Federal spending has peaked before.

Assumption 2: Amrize can grow at 8-11% annually as an independent company. Under Holcim, this business had access to a global balance sheet and decades of institutional knowledge. As a newly independent company with $5.3B in debt, the M&A machine may slow. The 130-deal-in-6-years pace was achieved with Holcim's resources, credit rating, and deal pipeline.

Assumption 3: Jan Jenisch's magic transfers from Holcim to Amrize seamlessly. Jenisch transformed Holcim from a bureaucratic European conglomerate into a lean operator. But running a $12B North American pure-play is different from running a $30B+ global diversified company. The skill set may be partially different. And he is mortal - succession risk is real.

Assumption 4: Cement is permanently pricing-power business. In local markets with 2-3 producers, yes. But the import threat is not zero - cement can be shipped by sea from Turkey, China, and Mexico. If tariffs loosen or if domestic pricing becomes egregious, imports can and will arrive at coastal markets.

The Contrarian View

For the bears to be right, you need to believe some combination of:

The construction cycle is peaking, not beginning. Commercial construction (ABI < 50) is already contracting. Residential construction faces affordability constraints. Infrastructure spending could be delayed or redirected. The 2021-2024 revenue doubling was the cycle, not the start of one.
The spin-off premium is a sugar high. Spin-offs initially attract attention and momentum investors. Once the novelty fades and the company enters its first downturn as an independent entity, the premium evaporates. At 30x earnings, a mere reversion to 20x (still generous for a cyclical) implies a 33% drawdown.
ROE of 8.9% tells the truth. Despite the narrative of excellence, the actual return on equity is mediocre. This is a capital-intensive business with massive goodwill ($9B) that flatters ROIC calculations. Tangible ROE would be much higher, but you're paying for tangible book 14 times over - that's the market pricing in perpetual above-average growth.

The bears have a case. This is not a layup.

Simplest Thesis

Amrize owns irreplaceable cement and aggregates assets in the world's largest construction market, run by its best operator, but the stock price already reflects this excellence.

Why This Opportunity Exists

This is not a mispriced opportunity. It is a correctly priced high-quality business.

The deeper truth is that Amrize illustrates a persistent challenge for value investors: the best businesses almost never get cheap. The last time you could buy US cement assets cheaply was March 2020 (COVID crash) or 2008-2009 (financial crisis). In between, the market fully prices the moat, the management, and the infrastructure thesis.

The "opportunity" that exists is patience. The construction cycle will turn - it always does. When it does, cyclical businesses get crushed in the market regardless of their long-term quality. Cement stocks fell 40-60% in 2008-2009. If that happens again, Amrize at $25-35 would be a generational buying opportunity.

The spin-off structure may accelerate the eventual decline. As a new independent company, Amrize lacks the institutional shareholder base that stabilizes blue-chip stocks during downturns. Many current holders are index funds and momentum traders who bought the spin-off narrative. They will sell at the first sign of trouble.

What Would Change My Mind

I would move from WAIT to BUY if:

The stock falls below $48 (20x owner earnings, 5.4% FCF yield). This provides a reasonable margin of safety for a cyclical business.
Amrize demonstrates pricing power through a downturn. If cement pricing holds during a construction slowdown, it validates the "oligopoly" thesis more convincingly than any amount of bull-market data.
ROIC demonstrably exceeds 15% as an independent company over 2-3 years, proving the spin-off unlocked genuine value rather than just financial engineering.
A recession creates forced selling. The ideal scenario: a genuine US recession, construction volumes fall 15%, Amrize's earnings decline 25-30%, the stock drops to $30-40, but the balance sheet (1.1x leverage) ensures survival. That's when you buy cement.

Conversely, I would move to REJECT if: ROE persistently stays below 10%, M&A destroys value (goodwill write-downs), or Jenisch departs without a credible successor.

The Soul of This Business

The soul of Amrize is geographic inevitability.

When you own a cement plant and the quarries that feed it, and your nearest competitor's plant is 200 miles away, you don't need to be brilliant. You just need to show up and not be stupid. The geology does the work. The weight of the product creates the moat. The permitting process protects the castle.

This is what makes cement stocks seductive. The business is almost impossible to mess up. But "almost impossible to mess up" is not the same as "impossible to overpay for." Plenty of investors have bought great cement assets at peak-cycle valuations and waited 5-7 years to break even.

Jan Jenisch adds something rare to this equation: an operator who treats a $35 billion company like a startup, with no personal office, minimal bureaucracy, and $34 million of his own money on the line. That combination of structural advantage and operational intensity is genuinely rare.

But the stock market is not stupid either. It sees the same thing. At $64, you're paying full freight for quality. The patient investor recognizes quality, admires it, and waits for the market to forget about it. That day will come. Construction is cyclical. Memories are short. Markets panic. When they do, Amrize will be sitting there, making cement, moving aggregates, and minting cash - available at half today's price for those with the discipline to wait.

That's the soul of this investment: not whether the business is great (it is), but whether you have the patience to wait for a great price.

Executive Summary

3-Sentence Investment Thesis: Amrize is the largest cement producer in North America and a top-2 commercial roofing company, spun off from Holcim in June 2025 with $11.8B in revenue, 25.5% EBITDA margins, and $1.5B in annual free cash flow. The company operates in a structurally advantaged industry (cement is local, capital-intensive, and permit-constrained) with massive infrastructure tailwinds from the IIJA, CHIPS Act, and aging US infrastructure. However, at 30x trailing earnings and 13.5x EV/EBITDA, the stock is priced for perfection with limited margin of safety for a cyclical business that just delivered declining earnings.

Key Metrics Dashboard:

Metric	Value	Assessment
Revenue (FY2025)	$11.8B	Dominant scale
EBITDA Margin	25.5%	Strong but declining from 27.2%
FCF	$1.42B	Good but -13% YoY
Net Debt/EBITDA	1.1x	Conservative leverage
P/E (TTM)	30.0x	Expensive for cyclical
EV/EBITDA	13.5x	Premium to global peers
FCF Yield	4.0%	Below threshold
ROE	8.9%	Below 15% Buffett test
Insider Ownership	7.1%	Good alignment

Verdict: HOLD / WAIT for better entry. Strong business at an expensive price.

Phase 0: Business Understanding

What Does Amrize Do?

Amrize is North America's leading building solutions company, operating through two segments:

1. Building Materials ($8.5B revenue, 72% of total)

Cement: Largest producer in US and Canada with 13 plants. 22.4M tons produced in 2025. 1.7x the production volume of the next largest competitor. Their Ste. Genevieve, Missouri plant is the largest in North America.
Aggregates: 118.9M tons produced. Third-largest aggregates producer in North America behind Vulcan Materials and Martin Marietta. Top-2 in 85% of markets served.
Ready-Mix Concrete, Asphalt, and Other: Downstream integration providing distribution advantage.

2. Building Envelope ($3.3B revenue, 28% of total)

Commercial Roofing: Second-largest in North America
Residential Roofing, Insulation, Weatherization
Adhesives & Sealants

How Does Amrize Make Money?

The business model is fundamentally local. Cement and aggregates have high weight-to-value ratios, meaning transport costs limit the effective competitive radius to ~200 miles from a plant. This creates natural local oligopolies. Revenue comes from:

Selling cement and aggregates to construction projects (infrastructure, commercial, residential)
Downstream integration through ready-mix concrete and asphalt operations
Building envelope products for the roofing and wall systems market
Acquisitions - 130 deals over 6 years (>20/year), adding ~$3.8B in cumulative revenue

Corporate History

Holcim (formerly LafargeHolcim) built this North American platform over decades
Jan Jenisch became Holcim CEO in 2017, transformed the business
Revenue doubled from $6B to $12B between 2021-2024
Spun off as Amrize on June 23, 2025
Listed on NYSE and SIX Swiss Exchange
"Local for local" philosophy - all products made in North America

Phase 1: Risk Analysis (Inversion - "How Can This Go Wrong?")

Top 10 Risks

#	Risk	Probability	Severity	Expected Impact
1	Construction downturn / recession	25%	-35%	-8.8%
2	Cement overcapacity from imports or new plants	15%	-25%	-3.8%
3	Carbon regulation / cement decarbonization costs	20%	-20%	-4.0%
4	Acquisition integration failures (aggressive M&A)	15%	-20%	-3.0%
5	Key-man risk (Jan Jenisch departure)	10%	-25%	-2.5%
6	Rising interest rates impacting construction demand	20%	-15%	-3.0%
7	Goodwill impairment ($9B on balance sheet)	10%	-20%	-2.0%
8	Tariff/trade policy reversal benefiting imports	10%	-15%	-1.5%
9	Overvaluation correction (spin-off premium fading)	30%	-20%	-6.0%
10	Raw material / energy cost inflation	20%	-10%	-2.0%

Total Expected Downside: -36.6%

Risk Deep Dive

1. Construction Cyclicality (HIGH RISK) This is a cyclical business. Revenue went from $8.1B (2021) to $11.8B (2025), driven by a post-COVID construction boom and infrastructure spending. The Architecture Billings Index has been below 50 (contraction) for commercial construction. FY2025 already showed margin compression (operating margin fell from 18.4% to 16.5%) and revenue growth stalled at 0.9%. A genuine recession could cut earnings by 30-40%.

2. Goodwill Risk ($9B) Goodwill is $9.0B out of $24.2B total assets (37%). This represents the premium paid for 130+ acquisitions. If the market turns and acquired businesses underperform, significant impairment charges are possible.

3. Carbon Regulation Cement production is one of the most carbon-intensive industrial processes (~8% of global CO2 emissions). Future carbon taxes or stricter regulations could significantly increase production costs. Amrize is investing in lower-carbon products (ECOPlanet), but the transition cost is uncertain.

4. Valuation Risk At 30x trailing earnings and 13.5x EV/EBITDA, Amrize is priced at a premium to global cement peers (7-8x EBITDA) and closer to premium US aggregates players (MLM at 22-24x P/E). This premium pricing leaves little margin of safety. Any earnings miss could trigger significant multiple compression.

Phase 2: Financial Analysis

Revenue & Growth

Year	Revenue	Growth	EBITDA	Margin
2021	$8,132M	-	$2,012M	24.7%
2022	$10,726M	+31.9%	$2,545M	23.7%
2023	$11,677M	+8.9%	$2,752M	23.6%
2024	$11,704M	+0.2%	$3,039M	26.0%
2025	$11,815M	+0.9%	$2,863M	24.2%

Revenue CAGR (2021-2025): 9.8% EBITDA CAGR (2021-2025): 9.2%

Observation: Revenue growth has stalled since 2024. The 2021-2022 surge was driven by price increases and acquisitions. Organic growth has slowed materially.

Profitability Analysis

Metric	FY2025	FY2024	FY2023	5-Yr Avg
Gross Margin	25.7%	26.2%	23.7%	24.2%
Operating Margin	16.5%	18.4%	16.2%	16.6%
Net Margin	10.0%	10.9%	8.2%	9.8%
EBITDA Margin	24.2%	26.0%	23.6%	24.3%
FCF Margin	12.0%	14.0%	12.0%	12.0%

Assessment: Margins are good but not exceptional for a market leader. FY2024 appears to have been a peak margin year, with FY2025 reverting toward the mean. The company is not a high-margin compounder - it's a capital-intensive industrial business with decent but not outstanding profitability.

Return on Capital

Metric	Calculation	Value	Assessment
ROE	$1,185M / $13,254M	8.9%	FAILS Buffett 15% test
ROIC (approx)	NOPAT / IC	~13%	Acceptable
ROA	$1,185M / $24,249M	4.9%	Low

ROE Concern: The 8.9% ROE is well below the 15% threshold I require. However, this is partly because equity was significantly boosted by the spin-off restructuring (equity jumped from $9.9B to $13.3B in 2025 as Holcim transferred net assets). Pre-spin-off ROE using 2024 equity would be ~12.8% - still below 15%.

The ROIC of ~13% is more relevant and suggests the business earns above its cost of capital, but not by a wide margin for a company with these advantages.

Free Cash Flow Analysis

Year	OCF	CapEx	FCF	FCF/NI	FCF/Revenue
2021	$1,492M	$394M	$1,098M	131%	13.5%
2022	$1,988M	$488M	$1,500M	135%	14.0%
2023	$2,036M	$630M	$1,406M	147%	12.0%
2024	$2,282M	$642M	$1,640M	129%	14.0%
2025	$2,208M	$788M	$1,420M	120%	12.0%

FCF Quality: GOOD. FCF consistently exceeds net income, indicating earnings quality is high. The business converts EBITDA to FCF at ~50%, which is solid for a capital-intensive industrial company. CapEx is increasing ($788M in 2025 vs. ~$500M historically) as the company invests in capacity expansion.

Owner Earnings (Buffett Method)

Net Income:              $1,185M
+ D&A:                   $914M
- Maintenance CapEx:     ($500M est.)
= Owner Earnings:        ~$1,600M

Per Share: $1,600M / 553M = ~$2.89
Owner Earnings Yield: $2.89 / $64.16 = 4.5%

Balance Sheet Strength

Metric	FY2025	Assessment
Net Debt	$3,347M	Manageable
Net Debt/EBITDA	1.1x	Conservative
Interest Coverage	~6.5x (est.)	Adequate
Goodwill/Assets	37%	Elevated - watch
Tangible Equity	$2,504M	Thin after goodwill deduction
Current Ratio	1.4x	Healthy

The balance sheet improved dramatically in 2025 - long-term debt was reduced from $8.5B to $4.9B as part of the spin-off restructuring. The 1.1x net leverage is very conservative for the industry.

Concern: Goodwill at $9B and intangibles at $1.7B mean that tangible book value is only $2.5B against a $35B market cap. Price/Tangible Book is 14x - a sign of significant premium.

Valuation

Current Market Valuation:

Metric	AMRZ	MLM	VMC	CRH	SUM
P/E (TTM)	30.0x	30-35x	35-40x	20-22x	25-28x
EV/EBITDA	13.5x	17-19x	18-20x	10-12x	12-14x
FCF Yield	4.0%	2-3%	2-3%	4-5%	3-4%

Observation: AMRZ trades at a discount to pure-play US aggregates names (MLM, VMC) but at a premium to global cement peer CRH. This makes sense - AMRZ is a hybrid (cement + roofing), not a pure aggregates play.

DCF Valuation:

Assumptions:

Base FCF: $1,420M (FY2025)
Growth Years 1-3: 8% (guided EBITDA growth 8-11%, adjusted down)
Growth Years 4-5: 5%
Growth Years 6-10: 3%
Terminal Growth: 2.5%
Discount Rate: 9%

Scenario	FCF Growth	Terminal Multiple	Fair Value/Share
Bull	10% Y1-3, 6% Y4-10	15x	$75
Base	8% Y1-3, 4% Y4-10	12x	$58
Bear	3% Y1-3, 2% Y4-10	10x	$40

DCF Fair Value Range: $40 - $75, midpoint ~$58

At $64.16, the stock trades 10% above my base-case fair value. It's not egregiously overvalued, but there's no margin of safety.

Owner Earnings Valuation:

Owner Earnings: ~$1,600M
Required Return: 9%
Growth: 5%
Value = $1,600M / (9% - 5%) = $40B
Per Share: $40B / 553M = $72

This suggests fair value around $58-72 depending on growth assumptions.

Phase 3: Moat Analysis

Moat Sources

1. Local Oligopoly in Cement (WIDE MOAT) Cement has a high weight-to-value ratio, making it uneconomic to transport more than ~200 miles. New cement plants require massive capital ($500M+) and years of permitting. In many US markets, Amrize is one of only 2-3 producers, creating local oligopoly pricing power. This is the strongest moat source.

2. Scale & Distribution Network (WIDE MOAT) With 1,000+ sites across every US state and Canadian province, Amrize's distribution network is essentially impossible to replicate. The cost to build this infrastructure from scratch would be tens of billions. This network enables cross-selling across product lines.

3. Vertical Integration (NARROW MOAT) Cement -> Aggregates -> Ready-Mix -> Roofing creates a vertically integrated model that allows the company to capture more value per construction project. However, this is replicable by well-capitalized competitors.

4. Regulatory Barriers to Entry (NARROW MOAT) Cement plants face years of environmental permitting. Aggregate quarries require mining permits that take 5-10 years to obtain. This limits new supply. However, existing competitors also have permits.

5. "Made in America" Positioning (DEVELOPING) 100% domestic production means zero tariff exposure. In the current political environment, this is a marketing and supply chain advantage, though not a permanent moat.

Moat Assessment

Factor	Rating	Evidence
Pricing Power	Moderate	Cement pricing has increased, but constrained by housing affordability
Customer Switching Costs	Low	Cement is a commodity; customers buy on price and availability
Network Effects	None	Not applicable
Scale Advantages	High	Largest producer with 1.7x volume advantage
Regulatory Barriers	Moderate	Permitting protects existing capacity

Overall Moat Rating: NARROW-TO-WIDE

The moat is real but nuanced. In local cement markets, the moat is wide - it's a natural oligopoly. But the overall business (including building envelope, which faces more competition) rates as narrow-to-wide. The commodity nature of the products limits pricing power despite market leadership.

Moat Durability

10-Year View: Strong. US infrastructure needs are massive and growing. Cement demand will persist.
20-Year View: Moderate risk from carbon regulation. The shift to low-carbon cement could change cost structures and competitive dynamics.
Trend: Stable to slightly widening (acquisitions consolidating the market further)

Phase 4: Decision Synthesis

Management Quality

Jan Jenisch (Chairman & CEO)

Transformed Holcim during 2017-2025 tenure
Personally invested $34M+ in AMRZ shares post-spin-off
1.5M shares (~$96M at current prices)
"Local for local" philosophy - 150 HQ employees out of 19,000
No personal office - anti-bureaucracy culture
Completed 130 M&A deals in 6 years while improving margins
Insiders collectively own 7.1% (~$2.5B)

Assessment: EXCELLENT. Jenisch has massive personal skin in the game and a proven track record. His willingness to leave the Holcim CEO role to run Amrize signals deep conviction. The anti-bureaucracy culture is refreshing for a $35B company.

Concern: Key-man risk is real. If Jenisch departs, the narrative and execution quality could suffer.

Capital Allocation

Priority	Rating	Evidence
Organic Investment	Good	$788M CapEx in 2025, expanding capacity
M&A	Excellent Track Record	130 deals, disciplined approach, improving margins
Debt Reduction	Excellent	Net leverage from 2.3x to 1.1x in one year
Dividends	New	$0.44/share special + $0.44 ordinary = 1.4% yield
Buybacks	New	$1B authorization announced

Peer Comparison

Metric	AMRZ	MLM	VMC	CRH
Revenue	$11.8B	~$6B	~$8B	~$35B
EBITDA Margin	25.5%	30%+	28%+	16%
Net Debt/EBITDA	1.1x	1.5x	2.0x	1.0x
P/E	30x	32x	38x	21x
FCF Yield	4.0%	2.5%	2.0%	5%

Amrize trades at a reasonable premium to CRH (which has global operations) but at a discount to pure-play US aggregates names. The lower EBITDA margin vs. MLM/VMC reflects the lower-margin building envelope segment.

Expected Return Analysis

Scenario Analysis (5-Year Horizon):

Scenario	Prob.	EPS (2030)	P/E	Price	Return
Bull	25%	$4.00	25x	$100	+56%
Base	50%	$3.20	20x	$64	0%
Bear	25%	$1.80	15x	$27	-58%

Probability-Weighted Return: -0.5% + Dividends (~1.4%/yr x 5): +7% = Total Expected Return: ~6.5% over 5 years

This is below my 10% hurdle rate and well below the expected return of a concentrated portfolio.

Position Sizing

Criteria	Score	Weight	Weighted
Quality	7/10	25%	1.75
Moat	7/10	25%	1.75
Valuation	4/10	30%	1.20
Management	9/10	20%	1.80
Total			6.50/10

Recommended Allocation: 0% (WAIT)

The business quality is high, management is excellent, but the valuation does not provide adequate margin of safety. The stock needs to fall 20-30% before it becomes compelling.

Entry Prices

Level	Price	P/E	FCF Yield	EV/EBITDA	Trigger
Strong Buy	$40	17x	6.5%	9.0x	Recession, major correction
Accumulate	$48	20x	5.4%	10.5x	Market pullback, earnings miss
Fair Value	$58	25x	4.5%	12.0x	Current intrinsic value estimate
Current	$64	30x	4.0%	13.5x	Priced for perfection
Sell	$80	37x	3.2%	16.0x	Speculative excess

Monitoring Triggers

Trigger	Action	Threshold
Price drops below $48	Begin accumulating	-25% from current
EBITDA margin drops below 22%	Reassess thesis	Structural margin decline
Net leverage exceeds 3.0x	Review position	Over-leveraged for cyclical
Jenisch departure	Immediate reassessment	Key-man risk materializes
US infrastructure spending cut	Reduce thesis conviction	Policy reversal
Cement price war	Monitor closely	Competitive dynamics shift

Conclusion

Amrize is a high-quality business with a genuine competitive moat in North American cement and building materials. Jan Jenisch is an exceptional operator with massive personal conviction demonstrated by $34M in open-market purchases. The company's "local for local" strategy, dominant market position, and infrastructure tailwinds support a strong long-term thesis.

However, quality has its price, and at 30x trailing earnings for a cyclical industrial business showing declining margins and flat revenue growth, the current valuation offers no margin of safety. The stock is fairly priced at best and potentially overvalued given the cyclical risks.

The patient investor's path: Add AMRZ to the watchlist and wait for a recession-induced pullback or an earnings disappointment that brings the stock to $48 or below. At that price, the combination of quality, moat, and management would make this a compelling investment.

Recommendation: WAIT Target Entry: $48 (accumulate) / $40 (strong buy) Quality Grade: B+ (excellent business, premium price) Tier: T2 Resilient